3-iodopindolol has been researched along with du-21220 in 1 studies
| Studies (3-iodopindolol) | Trials (3-iodopindolol) | Recent Studies (post-2010) (3-iodopindolol) | Studies (du-21220) | Trials (du-21220) | Recent Studies (post-2010) (du-21220) |
|---|---|---|---|---|---|
| 94 | 0 | 0 | 994 | 153 | 101 |
| Protein | Taxonomy | 3-iodopindolol (IC50) | du-21220 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, PL; Maguire, ME; Moore, JJ; Moore, RM; Roberts, JM; Zink, E | 1 |
1 other study(ies) available for 3-iodopindolol and du-21220
| Article | Year |
|---|---|
Ritodrine: a beta-adrenergic receptor antagonist in human amnion.
Topics: Amnion; Binding, Competitive; Cyclic AMP; Dinoprostone; Epinephrine; Humans; Isoproterenol; Norepinephrine; Pindolol; Receptors, Adrenergic, beta; Ritodrine | 1993 |